期刊
GENOMICS
卷 93, 期 1, 页码 13-16出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygeno.2008.07.006
关键词
Biomarker; Cancer; Gene Expression; High-dimensional data; Proteomics
With the development of new technologies for assaying biological activity on a global basis in experimental samples, various new -omics signatures have beer, developed to predict disease progression. Such signatures hold the potential to alter the nature of clinical management of human disease. In this article, we describe some necessary statistical considerations needed to take these signatures from the discovery phase to a clinically useful assay. Much of the work discussed is in the area of cancer. (C) 2008 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据